- Scheme Category:
- Equity Scheme >
- Sectoral/Thematic Funds
NAV: ₹ ↓ -0.72%
NAV chart
SMA (Simple Moving Average)
- 50 SMA
- 100 SMA
- 200 SMA
- 400 SMA
Returns
CAGR returns till date
CAGR returns of Tata India Pharma & Healthcare Fund-Regular Plan-Growth and its peers as on 1 September, 2026| Name | YTD | 1D | 1W | 1M | 3M | 1Y | 3Y | 5Y | 7Y | 10Y |
|---|---|---|---|---|---|---|---|---|---|---|
| Tata India Pharma & Healthcare Fund-Regular Plan-Growth | 11.52% | -0.72% | -0.5% | -0.19% | 8.63% | 10.62% | 19.46% | 13.12% | 21.13% | 13.44% |
| SBI MNC FUND - REGULAR PLAN -GROWTH | 18.36% | -0.65% | 0.39% | 3.16% | 12.3% | 17.7% | 7.88% | 8.46% | 14.49% | 11.28% |
| SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH | 24.05% | -0.97% | 0.62% | 1.74% | 14.42% | 21.8% | 23.77% | 17.45% | 24.86% | 13.83% |
| SBI COMMA Fund - REGULAR PLAN - Growth | 7.06% | 0.01% | 0.38% | 1.99% | 1.43% | 15.19% | 16.26% | 11.33% | 19.93% | 15.05% |
| SBI ESG Exclusionary Strategy Fund - Regular Plan - Growth | -2.73% | -1.03% | -0.99% | -0.66% | 5.03% | 1.5% | 9.62% | 8.35% | 13.01% | 11.07% |
| SBI INFRASTRUCTURE FUND - REGULAR PLAN - GROWTH | 0.35% | 0.1% | -2.14% | -2.9% | -1.18% | 4.27% | 13.61% | 15.95% | 19.39% | 14.37% |
Discrete returns (yearly)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns | -14.26% | 4.15% | -2.5% | 5.4% | 65.31% | 18.13% | -8.24% | 37.51% | 40.42% | -5.37% |
Discrete returns (monthly)
| Month | Nov 2025 | Dec 2025 | Jan 2026 | Feb 2026 | Mar 2026 | Apr 2026 | May 2026 | Jun 2026 | Jul 2026 | Aug 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns | 0.09% | -1.76% | -5.72% | 4.8% | -6.41% | 6.81% | 3.13% | 4.41% | 4.28% | 0.53% |
Returns from spefic dates
| Description | CAGR returns from 18 Oct 2021 (Nifty 50 2021 high) | CAGR returns from 26 Sep 2024 (Nifty 50 2024 high) |
|---|---|---|
| Returns | 13.83% | 4.11% |
Portfolio
Asset allocation
| Equity | Debt | Realestate | Commodities | Cash & Equivalents |
|---|---|---|---|---|
| 99.13% | 0.00% (Arbitrage: 0.00%) | 0.00% | 0.00% | 0.87% |
Equity
| Name | Symbol / ISIN | Sector | Weight % | Other links |
|---|---|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES LTD | SUNPHARMA (INE044A01036) | Pharmaceuticals & Biotechnology | 8.59% | |
| DIVI LABORATORIES LTD | DIVISLAB (INE361B01024) | Pharmaceuticals & Biotechnology | 6.36% | |
| HEALTHCARE GLOBAL ENTERPRISES LTD | HCG (INE075I01017) | Healthcare Services | 5.85% | |
| ABBOTT INDIA LTD | ABBOTINDIA (INE358A01014) | Pharmaceuticals & Biotechnology | 5.63% | |
| RAINBOW CHILDRENS MEDICARE LTD | RAINBOW (INE961O01016) | Healthcare Services | 4.90% | |
| GLAXOSMITHKLINE PHARMACEUTICALS LTD | GLAXO (INE159A01016) | Pharmaceuticals & Biotechnology | 4.66% | |
| CIPLA LTD | CIPLA (INE059A01026) | Pharmaceuticals & Biotechnology | 4.53% | |
| DR REDDYS LABORATORIES LTD | DRREDDY (INE089A01031) | Pharmaceuticals & Biotechnology | 4.25% | |
| MAX HEALTHCARE INSTITUTE LTD | MAXHEALTH (INE027H01010) | Healthcare Services | 4.07% | |
| APOLLO HOSPITALS ENTERPRISE LTD | APOLLOHOSP (INE437A01024) | Healthcare Services | 3.90% | |
| BAYER CROPSCIENCE LTD | BAYERCROP (INE462A01022) | Fertilizers & Agrochemicals | 3.26% | |
| FORTIS HEALTHCARE LTD | FORTIS (INE061F01013) | Healthcare Services | 3.12% | |
| PFIZER LTD | PFIZER (INE182A01018) | Pharmaceuticals & Biotechnology | 3.06% | |
| MANKIND PHARMA LTD | MANKIND (INE634S01028) | Pharmaceuticals & Biotechnology | 3.02% | |
| SYNGENE INTERNATIONAL LTD | SYNGENE (INE398R01022) | Healthcare Services | 2.95% | |
| SAI LIFE SCIENCES LTD | SAILIFE (INE570L01029) | Pharmaceuticals & Biotechnology | 2.89% | |
| LUPIN LTD | LUPIN (INE326A01037) | Pharmaceuticals & Biotechnology | 2.64% | |
| ALKEM LABORATORIES LTD | ALKEM (INE540L01014) | Pharmaceuticals & Biotechnology | 2.58% | |
| PROCTER & GAMBLE HEALTH LTD | PGHL (INE199A01012) | Pharmaceuticals & Biotechnology | 2.42% | |
| FDC LTD | FDC (INE258B01022) | Pharmaceuticals & Biotechnology | 2.39% | |
| DR. LAL PATH LABS LTD | LALPATHLAB (INE600L01024) | Healthcare Services | 2.17% | |
| GLOBAL HEALTH LTD | MEDANTA (INE474Q01031) | Healthcare Services | 2.13% | |
| CONCORD BIOTECH LTD | CONCORDBIO (INE338H01029) | Pharmaceuticals & Biotechnology | 1.91% | |
| SUMITOMO CHEMICAL INDIA LTD | SUMICHEM (INE258G01013) | Fertilizers & Agrochemicals | 1.59% | |
| AJANTA PHARMA LTD | AJANTPHARM (INE031B01049) | Pharmaceuticals & Biotechnology | 1.53% | |
| NEULAND LABORATORIES LTD | NEULANDLAB (INE794A01010) | Pharmaceuticals & Biotechnology | 1.25% | |
| GILLETTE INDIA LTD | GILLETTE (INE322A01010) | Personal Products | 1.15% | |
| METROPOLIS HEALTHCARE LTD | METROPOLIS (INE112L01020) | Healthcare Services | 1.12% | |
| MANIPAL HEALTH ENTERPRISES LTD | (INE459N01021) | Healthcare Services | 0.97% | |
| BASF INDIA LTD | BASF (INE373A01013) | Chemicals & Petrochemicals | 0.97% | |
| JUBILANT PHARMOVA LTD | JUBLPHARMA (INE700A01033) | Pharmaceuticals & Biotechnology | 0.83% | |
| DR. AGARWALS HEALTH CARE LTD | AGARWALEYE (INE943P01029) | Healthcare Services | 0.67% | |
| SANOFI CONSUMER HEALTHCARE INDIA LTD | SANOFICONR (INE0UOS01011) | Pharmaceuticals & Biotechnology | 0.55% | |
| BIOCON LTD | BIOCON (INE376G01013) | Pharmaceuticals & Biotechnology | 0.52% | |
| ZIM LABORATORIES LTD | ZIMLAB (INE518E01015) | Pharmaceuticals & Biotechnology | 0.46% | |
| SANOFI INDIA LTD | SANOFI (INE058A01010) | Pharmaceuticals & Biotechnology | 0.23% | |
| ANTHEM BIOSCIENCES LTD | ANTHEM (INE0CZ201020) | Pharmaceuticals & Biotechnology | 0.01% |
Debt
| Name | Rating | Weight % |
|---|
Portfolio data is as on date 31 July, 2026
NAV history
Tata India Pharma & Healthcare Fund-Regular Plan-Growth - 30 days NAV (Net asset value) history
| Date | NAV | % change |
|---|---|---|
| 1 September, 2026 | 33.6409 | -0.72% |
| 31 August, 2026 | 33.8832 | 0.28% |
| 28 August, 2026 | 33.7876 | -0.21% |
| 27 August, 2026 | 33.8592 | 0.03% |
| 26 August, 2026 | 33.8489 | 0.11% |
| 25 August, 2026 | 33.8101 | 0.58% |
| 24 August, 2026 | 33.6138 | -0.06% |
| 21 August, 2026 | 33.6341 | -0.12% |
| 20 August, 2026 | 33.6753 | -0.17% |
| 19 August, 2026 | 33.7312 | 0.18% |
| 18 August, 2026 | 33.6694 | 0.39% |
| 17 August, 2026 | 33.5400 | -0.27% |
| 14 August, 2026 | 33.6323 | -0.15% |
| 13 August, 2026 | 33.6843 | -0.4% |
| 12 August, 2026 | 33.8192 | -0.54% |
| 11 August, 2026 | 34.0013 | 0.24% |
| 10 August, 2026 | 33.9191 | 0.27% |
| 7 August, 2026 | 33.8266 | -0.04% |
| 6 August, 2026 | 33.8409 | -0.06% |
| 5 August, 2026 | 33.8626 | -0.13% |
| 4 August, 2026 | 33.9066 | -0.2% |
| 3 August, 2026 | 33.9757 | 0.8% |
| 31 July, 2026 | 33.7044 | 0.08% |
| 30 July, 2026 | 33.6767 | -0.16% |
| 29 July, 2026 | 33.7302 | 0.97% |
| 28 July, 2026 | 33.4067 | 0.08% |
| 27 July, 2026 | 33.3795 | 1.25% |
| 24 July, 2026 | 32.9674 | -0.19% |
| 23 July, 2026 | 33.0297 | -0.52% |
| 22 July, 2026 | 33.2016 |
FAQ (Frequently asked questions)
What is latest/current NAV/price of Tata India Pharma & Healthcare Fund-Regular Plan-Growth?
The latest NAV of Tata India Pharma & Healthcare Fund-Regular Plan-Growth is 33.6409 as on 1 September, 2026.What are YTD (year to date) returns of Tata India Pharma & Healthcare Fund-Regular Plan-Growth?
The YTD (year to date) returns of Tata India Pharma & Healthcare Fund-Regular Plan-Growth are 11.52% as on 1 September, 2026.What are 1 year returns of Tata India Pharma & Healthcare Fund-Regular Plan-Growth?
The 1 year returns of Tata India Pharma & Healthcare Fund-Regular Plan-Growth are 10.62% as on 1 September, 2026.What are 3 year CAGR returns of Tata India Pharma & Healthcare Fund-Regular Plan-Growth?
The 3 year annualized returns (CAGR) of Tata India Pharma & Healthcare Fund-Regular Plan-Growth are 19.46% as on 1 September, 2026.What are 5 year CAGR returns of Tata India Pharma & Healthcare Fund-Regular Plan-Growth?
The 5 year annualized returns (CAGR) of Tata India Pharma & Healthcare Fund-Regular Plan-Growth are 13.12% as on 1 September, 2026.What are 10 year CAGR returns of Tata India Pharma & Healthcare Fund-Regular Plan-Growth?
The 10 year annualized returns (CAGR) of Tata India Pharma & Healthcare Fund-Regular Plan-Growth are 13.12% as on 1 September, 2026.What is LTCG (Long term capital gain) and STCG (Short term capital gain) tax for Tata India Pharma & Healthcare Fund-Regular Plan-Growth?
Tata India Pharma & Healthcare Fund-Regular Plan-Growth is equity oriented mutual fund. Various capital gain taxes are applicable as below (Effective for redemption after July 23, 2024 and from FY 2024-25)Holding period Tax rate Less than 1 year (STCG) 20% More than 1 year (LTCG) Tax free upto Rs. 1.25 lakhs. 12.5% on rest amount.